ArticleScandinavian journal of primary health care2014
Drug treatment at the end of life: an epidemiologic study in nursing homes.
Article in Scandinavian journal of primary health care, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 33 citations in OpenAlex.
- Variations in Prescribing Rates of End-of-Life Medications Among Long-Term Care Residents in Alberta Compared with Ontario-a Retrospective Cohort Study.Canadian geriatrics journal : CGJ · 2025Article
- Prescribing practices, patterns, and potential harms in patients receiving palliative care: A systematic scoping review.Exploratory research in clinical and social pharmacy · 2021Article
- Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards.International journal of geriatric psychiatry · 2021Observational
- Frailty, Complexity, and Priorities in the Use of Advanced Palliative Care Resources in Nursing Homes.Medicina (Kaunas, Lithuania) · 2021Article
- Associations between Length of Stay in Long Term Care Facilities and End of Life Care. Analysis of the PACE Cross-Sectional Study.International journal of environmental research and public health · 2020Article
- Prospective Evaluation of Intensity of Symptoms, Therapeutic Procedures and Treatment in Palliative Care Patients in Nursing Homes.Journal of clinical medicine · 2020Article
- Polypharmacy patterns in the last year of life in patients with dementia.European journal of clinical pharmacology · 2019Article
- Assessing Potentially Inappropriate Medications in Nursing Home Residents by NORGEP-NH Criteria.Pharmacy (Basel, Switzerland) · 2019Article
- Opioid, antipsychotic and hypnotic use in end of life in long-term care facilities in six European countries: results of PACE.European journal of public health · 2019Article
- Quality of dying and quality of end-of-life care of nursing home residents in six countries: An epidemiological study.Palliative medicine · 2018Article
- Residential aged care residents and components of end of life care in an Australian hospital.BMC palliative care · 2018Article
- Drug Prescriptions in Nursing Home Residents during their Last 6 Months of Life: Data from the IQUARE Study.The journal of nutrition, health & aging · 2018Article
- Changes in Prescribing Symptomatic and Preventive Medications in the Last Year of Life in Older Nursing Home Residents.Frontiers in pharmacology · 2017Article
- "It is meaningful; I feel that I can make a difference" -A qualitative study about GPs' experiences of work at nursing homes in Sweden.BMC family practice · 2015Article
- An Observational Study on the Effects of Delayed Initiation of End-of-Life Care in Terminally ill Young Adults in the Intensive Care Unit.Indian journal of palliative careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo examine drug treatment in nursing home patients at the end of life, and identify predictors of palliative drug therapy.
designA historical cohort study.
settingThree urban nursing homes in Norway. SUBJECTS: All patients admitted from January 2008 and deceased before February 2013.
main outcome measuresDrug prescriptions, diagnoses, and demographic data were collected from electronic patient records. Palliative end-of-life drug treatment was defined on the basis of indication, drug, and formulation.
results524 patients were included, median (range) age at death 86 (19-104) years, 59% women. On the day of death, 99.4% of the study population had active prescriptions; 74.2% had palliative drugs either alone (26.9%) or concomitantly with curative/preventive drugs (47.3%). Palliative drugs were associated with nursing home, length of stay > 16 months (AOR 2.10, 95% CI 1.12-3.94), age (1.03, 1.005-1.05), and a diagnosis of cancer (2.12, 1.19-3.76). Most initiations of palliative drugs and withdrawals of curative/preventive drugs took place on the day of death.
conclusionPalliative drug therapy and drug therapy changes are common for nursing home patients on the last day of life. Improvements in end-of-life care in nursing homes imply addressing prognostication and earlier response to palliative needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.